-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901.O1.6 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: It's All About the Money!

Symposia: Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Bleeding disorders, Research, Adult, Clinical Practice (Health Services and Quality), Hemophilia, Bispecific Antibody Therapy, Clinical Research, Health outcomes research, Pediatric, Education, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Young adult , Technology and Procedures, Human, Study Population, Maternal Health, Pathology
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Marriott Grand Ballroom 2-4 (Marriott Marquis San Diego Marina)
Moderators:
Madhvi Rajpurkar, MD, and Lisa Baumann Kreuziger, MD, MS, ARRAY(0xf036f50)
Disclosures:
Baumann Kreuziger: CSL Behring: Research Funding; Takeda: Research Funding; Sanofi: Research Funding; Veralox: Research Funding.
2:00 PM

Daniel Wang1, Samira Glaeser-Khan, BS1*, Daniel Y Wang2*, Ranya Moshashaian Asl3*, Karthik Chetlapalli, MS, BS1, Satoko Ito, MD, PhD4, Adam Cuker, MD MS5 and George Goshua, MD, MSc6

1Yale School of Medicine, New Haven, CT
2Yale College, New Haven
3University of Vermont Larner College of Medicine, Burlington
4Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
5Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
6Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT

2:15 PM

Hanny Al-Samkari, MD1,2, Tracy Mayne, PhD3*, Sandra Texeira, PhD4*, Marianne S. Clancy, RDH, MPA5* and Eric Duhaime, MBA4*

1Harvard Medical School, Boston, MA
2Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA
3Slipstream IT, San Francisco, CA
4Diagonal Therapeutics, Cambridge, MA
5Cure HHT, Monkton, MD

2:30 PM

Thomas Majda1*, Janet S Lee1*, Randall Curtis, MBA2* and Stacey L Kowal, MS1*

1Genentech, Inc., South San Francisco, CA
2Factor VIII Computing, Berkeley, CA

2:45 PM

Bhavesh Mohan Lal, MD1, Jacob T Wooldridge2*, Mamatha Gaddam, MD3, Ankur Varma, MD3, Ginell R. Post, MD, PhD4* and Muthu V. Kumaran, MD3*

1University of Arkansas for Medical Sciences, Little Rock, Little Rock, AR
2University of Arkansas for Medical Sciences, Little Rock
3University of Arkansas for Medical Sciences, Little Rock, AR
4Univ. of Arkansas for Medical Sciences, Little Rock, AR

3:00 PM

Daniel Wang1, Daniel Y Wang2*, Samira Glaeser-Khan, BS1*, Ranya Moshashaian Asl3*, Karthik Chetlapalli, MS, BS1, Satoko Ito, MD, PhD4, Adam Cuker, MD MS5 and George Goshua, MD, MSc6

1Yale School of Medicine, New Haven, CT
2Yale College, New Haven
3University of Vermont Larner College of Medicine, Burlington
4Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
5Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
6Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT

3:15 PM

Sanjay J. Shah, MBBS1,2, Mona Nourani3* and Christine M. Knoll, MD4*

1Department of Child Health, Phoenix Children’s Hospital, University of Arizona College of Medicine, Chandler, AZ
2Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, AZ
3Department of Child Health, University of Arizona School of Medicine, Phoenix Arizona, AZ
4Phoenix Children's Hospital, Phoenix, AZ

*signifies non-member of ASH